Clinical Waste Removal Services for Waste Generated by Covid-19 Testing

Clinical Waste Removal Services for Waste Generated by Covid-19 Testing

This tender is being run to manage clinical waste generated through Covid-19 testing only.

United Kingdom-Milton Keynes: Clinical-waste collection services

2020/S 121-298118

Contract notice

Services

Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses

Official name: UK Biocentre Ltd
Postal address: Unit 2-3 Bradbourne Drive, Java Park, Tilbrook
Town: Milton Keynes
NUTS code: UKJ12 Milton Keynes
Postal code: MK7 8AT
Country: United Kingdom
E-mail: tenders@ukbiocentre.com
Telephone: +44 1614755386
Internet address(es):Main address: www.ukbiocentre.com

Address of the buyer profile: https://www.mytenders.co.uk/search/Search_AuthProfile.aspx?ID=AA38249

I.2)Information about joint procurement

I.3)Communication

The procurement documents are available for unrestricted and full direct access, free of charge, at: www.mytenders.co.uk
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: www.mytenders.co.uk

I.4)Type of the contracting authority

Body governed by public law

I.5)Main activity

Health

Section II: Object

II.1)Scope of the procurement

II.1.1)Title:

Clinical Waste Removal Services for Waste Generated by Covid-19 Testing

Reference number: UKBC001

II.1.2)Main CPV code

90524100 Clinical-waste collection services

II.1.3)Type of contract

Services

II.1.4)Short description:

UK Biocentre’s laboratories in Milton Keynes are being used to analyse swab samples to support the national effort against the coronavirus pandemic. They are one of the three lighthouse labs – the biggest network of diagnostic testing facilities our country has ever seen.

Operations have expanded rapidly to analyse swab samples to determine whether Covid-19 is present. We have repurposed existing laboratories and built new ones to provide the capacity required for such a significant undertaking.

As a by-product of the increased testing, the amount of clinical waste generated at UK Biocentre has increased and the existing contract in place does not support the volumes required by the Covid-19 testing. This tender is being run to manage clinical waste generated through Covid-19 testing only.

II.1.5)Estimated total value

II.1.6)Information about lots

This contract is divided into lots: no
II.2)Description
II.2.1)Title:

II.2.2)Additional CPV code(s)

34928480 Waste and rubbish containers and bins
90524200 Clinical-waste disposal services

II.2.3)Place of performance

NUTS code: UKJ12 Milton Keynes

II.2.4)Description of the procurement:

UK Biocentre estimates it is currently producing 10 tonnes of clinical waste per week and expects this to rise on a gradual basis to approximately 20 tonnes per week by the end of August 2020.

The clinical waste that will require removal initially are:

— 96-well 0.5ml plates

— ‘Centrefeed’ paper towel

— disposable labcoats

— disposable nitrile gloves

— pipette tips – 10 uL, 20 uL, 200 uL, 1 000 uL, 5 000 uL

— plastic outer swab transport tube 100 mm x 13 ml diameter

— clear plastic sample transport bag

— sample transport outer bag

— sample swab

— sample tube 80ml x 10ml diameter.

UK Biocentre is currently developing a service to carry out Covid-19 serology testing. If this project goes ahead an additional 20 000 to 50 000 tests per day will be carried out once the project has fully ramped up, which equates to approximately an additional 15 tonnes of waste per week. The clinical waste collection and disposal service may need to be flexible to support this study, if the project goes ahead, in addition to the Lighthouse Covid-19 testing. The clinical waste created by this project will be similar, but may be different, as the exact testing procedure has not yet been finalised.

II.2.5)Award criteria

Criteria below
Quality criterion – Name: Service and quality / Weighting: 20
Quality criterion – Name: Assurance of supply / Weighting: 20
Price – Weighting: 60
II.2.6)Estimated value

II.2.7)Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 24
This contract is subject to renewal: yes
Description of renewals:

The initial contract term will be 6 months, with the option to extend on further occasions by further 3 month periods up to a maximum contract length of 2 years, with the contract starting in early September 2020.

II.2.10)Information about variants

Variants will be accepted: no

II.2.11)Information about options

Options: yes
Description of options:

UK Biocentre is currently developing a service to carry out Covid-19 serology testing. If this project goes ahead an additional 20 000 to 50 000 tests per day will be carried out once the project has fully ramped up, which equates to approximately an additional 15 tonnes of waste per week. The clinical waste collection and disposal service may need to be flexible to support this study, if the project goes ahead,in addition to the lighthouse Covid-19 testing. The clinical waste created by this project will be similar, but may be different, as the exact testing procedure has not yet been finalised.

II.2.12)Information about electronic catalogues

II.2.13)Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information

III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers

III.1.2)Economic and financial standing

Selection criteria as stated in the procurement documents

III.1.3)Technical and professional ability

Selection criteria as stated in the procurement documents
III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.1)Information about a particular profession
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure

IV.1)Description

IV.1.1)Type of procedure

Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction

IV.1.8)Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: yes
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure

IV.2.2)Time limit for receipt of tenders or requests to participate

Date: 23/07/2020
Local time: 12:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates

IV.2.4)Languages in which tenders or requests to participate may be submitted:

English

IV.2.6)Minimum time frame during which the tenderer must maintain the tender

Tender must be valid until: 26/10/2020

IV.2.7)Conditions for opening of tenders

Date: 23/07/2020
Local time: 12:00

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no

VI.2)Information about electronic workflows

Electronic ordering will be used
Electronic invoicing will be accepted
Electronic payment will be used

VI.3)Additional information:

UK Biocentre reserves the right to withdraw from the procurement process and may decide not to award a contract as a result of this call for competition. UK Biocentre shall not be liable for any costs or expenses incurred by any bidder in considering and/or responding to the procurement process. Tenders and supporting documents must be priced in pounds sterling and all payments made under the contract will be in pounds sterling, unless otherwise advised.

Any volume of waste data provided within this contract notice and/or the procurement documents is indicative only and there is no guarantee of any volumes or particular type of clinical waste, particularly given the position in relation to Covid-19 testing continues to evolve. The service (and levels of collections) will need to be flexible to support UK Biocentre in its testing activities.

The estimated contract value for the initial period of 6 months may be in the region of GBP 450 000 to GBP 500 000 but the value may vary (and therefore may be lower or higher than this range) given that we cannot currently predict Covid-19 tonnage levels and timing. As such, it is not possible to provide an overall maximum estimated value for the contract given the evolving nature of the Covid-19 pandemic and whether the contract will be extended up to the maximum 2 year period. However, based on the initial 6 month period highlighted above and whilst recognising the value may vary, the overall maximum value could be in the region of GBP 1.5 – 2.0 million.

Note: to register your interest in this notice and obtain any additional information please visit the myTenders Web Site at https://www.mytenders.co.uk/Search/Search_Switch.aspx?ID=219937

The buyer has indicated that it will accept electronic responses to this notice via the Postbox facility. A user guide is available at https://www.mytenders.co.uk/sitehelp/help_guides.aspx

Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems.

(MT Ref:219937)

VI.4)Procedures for review

VI.4.1)Review body

Official name: Public Procurement Review Service
Postal address: Cabinet Office
Town: London
Country: United Kingdom
VI.4.2)Body responsible for mediation procedures

VI.4.3)Review procedure

Precise information on deadline(s) for review procedures:

UK Biocentre will incorporate a standstill period at the point the decision in relation to the award of the contract is notified to bidders. The standstill period, which will be a minimum of ten (10) calendar days, provides time for unsuccessful bidders to lodge an appeal in regards to the award decision, before the contract is entered into.

VI.4.4)Service from which information about the review procedure may be obtained

VI.5)Date of dispatch of this notice:

22/06/2020